Our results differ from the effects of vitamin C on KRAS-mutant colon cancer reported by Cenigaonandia-Campillo et al., suggesting that different treatments may exploit unique metabolic vulnerabilities [30]. This evidence concerns the gene KRAS and malignant colon neoplasm.